本页面由Tiger Trade Technology Pte. Ltd.提供服务

CRISPR Therapeutics AG

51.55
-1.8400-3.45%
盘后:51.52-0.0300-0.06%19:11 EDT
成交量:110.57万
成交额:5,735.20万
市值:49.85亿
市盈率:-10.83
高:53.21
开:52.91
低:51.40
收:53.39
52周最高:78.00
52周最低:44.12
股本:9,669.26万
流通股本:9,316.62万
量比:0.53
换手率:1.19%
股息:- -
股息率:- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
净资产收益率:-26.09%
总资产收益率:-14.20%
市净率:2.85
市盈率(LYR):-7.97

数据加载中...

2019/12/16

重要事件披露

Current report, items 1.01, 1.02, and 2.01
2019/11/26

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/22

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/19

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2019/10/28

重要事件披露

Current report, items 2.02 and 9.01
2019/10/28

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/30

重要事件披露

Current report, items 1.01 and 9.01
2019/08/05

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/29

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/07/29

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/07/29

重要事件披露

Current report, items 2.02 and 9.01
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/28

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/06/26

重要事件披露

Current report, item 8.01
2019/06/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities